MXCT Insider Trading Activity and SEC Form 4 Filings
MXCT insider trading summary
Over the past 12 months, insiders at Maxcyte, Inc. (MXCT) reported 1 sale worth $8K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $8K.
Latest MXCT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 17, 2026 | Douglas J Swirsky | Chief Financial Officer | Sell | $8K (10,142 @ $0.81) |
| Aug 13, 2025 | Maher Masoud | President and CEO | Buy | $103K (75,000 @ $1.37) |
| Aug 13, 2025 | Richard Douglas | Insider | Buy | $111K (80,000 @ $1.39) |
| Aug 13, 2025 | Stanley C Erck | Insider | Buy | $137K (100,000 @ $1.37) |
| Aug 13, 2025 | Douglas J Swirsky | Chief Financial Officer | Buy | $65K (50,000 @ $1.29) |
| Aug 13, 2025 | William W Brooke | Insider | Buy | $65K (50,000 @ $1.29) |
| Jun 25, 2025 | Rekha Hemrajani | Insider | Sell | $22K (10,684 @ $2.09) |
| Mar 18, 2025 | Douglas J Swirsky | Chief Financial Officer | Sell | $22K (6,939 @ $3.18) |
| Mar 18, 2025 | David I. Sandoval | General Counsel | Sell | $1K (353 @ $3.18) |
| Mar 18, 2025 | Ali Soleymannezhad | Chief Commercial Officer | Sell | $4K (1,211 @ $3.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.